Kendric Wang
Title
Cited by
Cited by
Year
The placental gene PEG10 promotes progression of neuroendocrine prostate cancer
S Akamatsu, AW Wyatt, D Lin, S Lysakowski, F Zhang, S Kim, C Tse, ...
Cell reports 12 (6), 922-936, 2015
1722015
Optimally discriminative subnetwork markers predict response to chemotherapy
P Dao, K Wang, C Collins, M Ester, A Lapuk, SC Sahinalp
Bioinformatics 27 (13), i205-i213, 2011
1152011
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer
AW Wyatt, F Mo, K Wang, B McConeghy, S Brahmbhatt, L Jong, ...
Genome biology 15 (8), 1-14, 2014
842014
GATA2 as a potential metastasis-driving gene in prostate cancer
YT Chiang, K Wang, L Fazli, RZ Qi, ME Gleave, CC Collins, PW Gout, ...
Oncotarget 5 (2), 451, 2014
592014
Stromal gene expression is predictive for metastatic primary prostate cancer
F Mo, D Lin, M Takhar, VR Ramnarine, X Dong, RH Bell, SV Volik, ...
European urology 73 (4), 524-532, 2018
472018
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
D Lin, X Dong, K Wang, AW Wyatt, F Crea, H Xue, Y Wang, R Wu, RH Bell, ...
Oncotarget 6 (3), 1806, 2015
472015
HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncology
R Shrestha, E Hodzic, T Sauerwald, P Dao, K Wang, J Yeung, ...
Genome research 27 (9), 1573-1588, 2017
322017
Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model
S Qu, K Wang, H Xue, Y Wang, R Wu, C Liu, AC Gao, PW Gout, ...
Molecular oncology 8 (2), 311-322, 2014
282014
HIT’nDRIVE: multi-driver gene prioritization based on hitting time
R Shrestha, E Hodzic, J Yeung, K Wang, T Sauerwald, P Dao, ...
International Conference on Research in Computational Molecular Biology, 293-306, 2014
132014
A meta-analysis approach for characterizing pan-cancer mechanisms of drug sensitivity in cell lines
K Wang, R Shrestha, AW Wyatt, A Reddy, J Lehár, Y Wang, A Lapuk, ...
PLoS One 9 (7), e103050, 2014
112014
Chromoplexy: a new paradigm in genome remodeling and evolution
K Wang, Y Wang, CC Collins
Asian journal of andrology 15 (6), 711, 2013
72013
GATA2: Potential role as a prostate cancer metastasis-driving gene
YT Chiang, K Wang, F Crea, C Collins, P Gout, Y Wang
Cancer Research 74 (19 Supplement), 2001-2001, 2014
22014
MP51-15 PREDICTIVE VALUE AND POTENTIALS FOR CO-TARGETED THERAPY OF STAT1 SIGNALING IN GEMCITABINE/CISPLATIN RESISTANT BLADDER CANCER
T Hayashi, K Ikeda*, R Seiler, RH Bell, S Ettinger, K Wang, HZ Oo, H Abdi, ...
The Journal of Urology 201 (Supplement 4), e729-e729, 2019
2019
Predictive value and potentials for co-targeted therapy of STAT1 signaling in gemcitabine/cisplatin resistant bladder cancer
T Hayashi, K Ikeda, R Seiler, RH Bell, S Ettinger, K Wang, HZ Oo, H Abdi, ...
European Urology Supplements 18 (1), e234, 2019
2019
925 STAT1 inhibition restored chemotherapy sensitivity in cisplatin/gemcitabine resistant bladder cancer
T Hayashi, R Seiler, R Bell, S Ettinger, K Wang, A Goriki, HZ Oo, S Awrey, ...
European Urology Supplements 3 (15), e925, 2016
2016
MP49-09 ACTIVATION OF IFN/STAT1 SIGNALING IN CISPLATIN/GEMCITABINE RESISTANT BLADDER CANCER
T Hayashi, R Seiler, RH Bell, S Ettinger, K Wang, S Awrey, K Gust, ...
The Journal of Urology 193 (4S), e606-e606, 2015
2015
A systems biology approach for identifying markers of chemotherapy response
K Wang
University of British Columbia, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–17